Search This Blog

Thursday, April 23, 2026

Cumberland to sell branded U.S. pharma portfolio to Apotex affiliate for $100 million cash

 

Cumberland to sell branded U.S. pharma portfolio to Apotex affiliate for $100 million cash and refocus on orphan drugs

  • Transaction is subject to shareholder approval and will transfer Cumberland's branded U.S. pharmaceutical portfolio to an Apotex affiliate.
  • Cumberland plans to focus on its retained orphan drug pipeline after divesting the branded portfolio.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)